Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Orchestra BioMed Holdings Inc.’s current trading price is -69.86% away from its 52-week high, while its distance from the 52-week low is 45.36%. The stock’s price range over this period has fluctuated between $4.85 and $23.39. The company, operating within the financial sector, had a trading volume of approximately 1.88 million for the day, which was noticeably higher than the average daily share volume of 91620.0 over the last 3 months.
At present, Orchestra BioMed Holdings Inc. (OBIO) has a stock price of $7.05. In the previous session, the stock saw a rise, peaking at $7.05 after an opening price of $5.68. The day’s lowest price was $5.46, and it closed at $5.66.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Orchestra BioMed Holdings Inc. experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $23.39 on 04/03/23, while the lowest price for the same period was registered at $4.85 on 09/13/23.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Orchestra BioMed Holdings Inc. (OBIO) has experienced a quarterly decline of -35.38% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 202.34M and boasts a workforce of 45 employees.
Orchestra BioMed Holdings Inc.: What Analysts Are Saying
As of right now, 2 analysts are rating Orchestra BioMed Holdings Inc. as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 9.89, with a change in price of -7.86. Similarly, Orchestra BioMed Holdings Inc. recorded 99,222 in trading volume during the last 100 days, posting a change of -52.72%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for OBIO stands at 0.11. Similarly, the long-term debt-to-equity ratio is also 0.11.
OBIO Stock Stochastic Average
Today’s raw stochastic average for Orchestra BioMed Holdings Inc. over the last 50 days is 69.84%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 83.97%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 42.11% and 24.61%, respectively.
OBIO Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Year to date metric has recorded a loss of -29.36%.However, over the last six months, we can see a stronger performance of -44.22%. Over the last 30 days, the price of OBIO has fallen by 32.02%. And in the last five days, it has surged by 13.89%.
